Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Mitsuo Kozuru"'
Autor:
Yu Yagi, Eriko Nakashima, Motohiko Ikeda, Yoshimichi Tachikawa, Eriko Fujioka, Takamitsu Matsushima, Hayato Utsunomiya, Youko Suehiro, Tatsuro Goto, Akiko Takamatsu, Hiroshi Takatsuki, Hirofumi Ohno, Taisuke Narazaki, Hiroki Muta, Makoto Oyama, Akie Hirata, Mariko Tsuda, Mitsuo Kozuru, Yuji Yufu, Ilseung Choi, Naokuni Uike, Emi Tanaka, Shojiro Haji, Kaname Miyashita, Junichi Kiyasu, Yasuhiro Tsukamoto, Yasuhiro Nakashima
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e445-e453
Background We retrospectively analyzed patients with untreated aggressive adult T-cell leukemia/lymphoma who received the modified EPOCH (mEPOCH) regimen. Patients and Methods Patients received up to 6 mEPOCH cycles. Etoposide (50 mg/m2/day), doxorub
Autor:
Shojiro, Haji, Junichi, Kiyasu, Yoshimichi, Tachikawa, Jiro, Toyonaga, Motohiko, Ikeda, Mariko, Tsuda, Yasuhiro, Tsukamoto, Mitsuo, Kozuru, Yuji, Yufu
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 57(6)
Light-chain deposition disease (LCDD) is a rare plasma cell neoplasm that secretes an abnormal immunoglobulin light chain, which is deposited in tissues, leading to organ dysfunction. Spontaneous splenic rupture is a rare and life-threatening complic
Publikováno v:
Acta Medica Scandinavica. 179:109-114
Publikováno v:
European Journal of Haematology. 42:460-465
Dual rearrangement of immunoglobulin and T-cell antigen receptor (beta, delta) genes was demonstrated in a case of Philadelphia chromosome-positive chronic myeloid leukemia (CML) in blast crisis. The blast cells, showing L2 morphology and high activi
Autor:
Hiroko Nouda, Kenichi Nakamura, Kousuke Tsuruno, Keiko Yano, Takuya Oda, Mitsuo Kozuru, Hiroshi Imura
Publikováno v:
Nihon Naika Gakkai Zasshi. 98:1711-1714
Autor:
Mitsuo Kozuru, Naokuni Uike, Mitsutoshi Tara, Masaharu Kasai, Tomomitsu Hotta, Masao Tomonaga, Chikara Mikuni, Yasuaki Yamada, Kunihiro Tsukasaki, Masanori Shimoyama, Koichi Araki, Kensei Tobinai, Kiyoshi Takatsuki
Publikováno v:
International Journal of Hematology. 77:164-170
Aggressive adult T-cell leukemia-lymphoma (ATL) generally has a very poor prognosis. Deoxycoformycin (DCF, pentostatin), an inhibitor of adenosine deaminase, has shown promising therapeutic efficacy for ATL. To develop a new effective therapy against
Autor:
Yasuaki Yamada, Masao Tomonaga, Haruhiko Fukuda, Shuichi Hanada, Atae Utsunomiya, Mitsutoshi Tara, Masayuki Sano, Shuichi Ikeda, Kiyoshi Takatsuki, Mitsuo Kozuru, Koichi Araki, Fumio Kawano, Miyuki Niimi, Kensei Tobinai, Tomomitsu Hotta, Masanori Shimoyama, null Other Members Of The Lymphoma Study
Publikováno v:
British Journal of Haematology. 113:375-382
This phase II trial was performed to evaluate the efficacy of a new granulocyte colony-stimulating factor (G-CSF)-supported multi-agent chemotherapy protocol, LSG15, for aggressive adult T-cell leukaemia-lymphoma (ATL). Ninety-six previously untreate
Autor:
Kiyoshi Mukai, Masao Tomonaga, Haruo Sugiyama, T. Hotta, Masanori Shimoyama, Kinuko Tajima, Dohi H, Akira B. Miura, Tsuneo Sasaki, Shiro Fukuhara, Takenaka T, Chikara Mikuni, Masami Hirano, Miyuki Niimi, Haruhiko Fukuda, Kaori Nasu, Mitsuo Kozuru, Hisamitsu Suzuki
Publikováno v:
Japanese Journal of Clinical Oncology. 30:146-152
Background: The main form of cytotoxic treatment for advanced Hodgkin’s disease (HD) is conventional dose multiagents chemotherapy. As HD is not common in Japan, we conducted a phase II study of the commonly used combination chemotherapy (CCT) regi
Autor:
Kinuko Tajima, Masanori Shimoyama, Tohru Kobayashi, Toshiaki Sai, Atsushi Oyama, Tomomitsu Hotta, Koichi Araki, Shiro Fukuhara, Hironobu Toki, Miyuki Niimi, Shigeru Shirakawa, Naohito Yamaguchi, Makoto Matsumoto, Kijo Deura, Isao Aoki, Haruhiko Fukuda, Mitsuo Kozuru, Masami Nagai, Kensei Tobinai, Tatsuo Abe, Chikara Mikuni, Susumu Konda
Publikováno v:
Japanese Journal of Clinical Oncology. 29:340-348
Background Patients with acute lymphocytic leukemia (ALL) and those with lymphoblastic lymphoma (LBL) have overlapping clinical and immunophenotypic features and they have been treated with the same or very similar chemotherapy regimens. The goal of
Autor:
Ilseung Choi, Toshiyasu Taniguchi, Naokuni Uike, Toru Motokura, Koichi Ohshima, Shigeo Nakamura, Tatsuro Goto, Yasushi Yatabe, Mitsuo Kozuru, Yuji Yufu
Publikováno v:
ResearcherID
BACKGROUND The t(11;14)(q13;q32) translocation with cyclin D1 overexpression commonly is found in multiple myeloma (MM) and in mantle cell lymphoma (MCL). Several reports have shown that p53 mutations in MCL lead to blastoid transformation and a wors